{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:08:46Z","timestamp":1791299326045,"version":"4.1.0"},"reference-count":52,"publisher":"Pharmaceutical Society of Japan","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological & Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2018]]},"DOI":"10.1248\/bpb.b17-00451","type":"journal-article","created":{"date-parts":[[2017,10,30]],"date-time":"2017-10-30T22:09:21Z","timestamp":1509401361000},"page":"36-46","source":"Crossref","is-referenced-by-count":45,"title":["Chelerythrine Inhibits Human Hepatocellular Carcinoma Metastasis <i>in Vitro<\/i>"],"prefix":"10.1248","volume":"41","author":[{"given":"Yuanzhang","family":"Zhu","sequence":"first","affiliation":[{"name":"Laboratory of Formula, School of Pharmacy, Shanghai University of Traditional Chinese Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingyi","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Traditional Chinese Medicine, School of Pharmacy, Shanghai University of Traditional Chinese Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guibiao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Traditional Chinese Medicine, School of Pharmacy, Shanghai University of Traditional Chinese Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingchun","family":"Wu","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Shanghai University of Traditional Chinese Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weicai","family":"Zhong","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Shanghai University of Traditional Chinese Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxiao","family":"Chu","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Shanghai University of Traditional Chinese Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Qian","sequence":"additional","affiliation":[{"name":"Laboratory of Formula, School of Pharmacy, Shanghai University of Traditional Chinese Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guofu","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Traditional Chinese Medicine, School of Pharmacy, Shanghai University of Traditional Chinese Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","unstructured":"1) Dizon DS, Krilov L, Cohen E, Gangadhar T, Ganz PA, Hensing TA, Hunger S, Krishnamurthi SS, Lassman AB, Markham MJ, Mayer E, Neuss M, Pal SK, Richardson LC, Schilsky R, Schwartz GK, Spriggs DR, Villalona-Calero MA, Villani G, Masters G. Clinical cancer advances 2016: annual report on progress against cancer from the american society of clinical oncology. J. Clin. Oncol.<\/i>, 34<\/b>, 987\u20131011 (2016)."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J. Clin.<\/i>, 61<\/b>, 69\u201390 (2011).","DOI":"10.3322\/caac.20107"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet<\/i>, 362<\/b>, 1907\u20131917 (2003).","DOI":"10.1016\/S0140-6736(03)14964-1"},{"key":"4","unstructured":"4) Carr BI. Hepatocellular carcinoma: current management and future trends. Gastroenterology<\/i>, 127<\/b> (Suppl. 1), S218\u2013S224 (2004)."},{"key":"5","unstructured":"5) Little SA, Fong Y. Hepatocellular carcinoma: current surgical management. Semin. Oncol.<\/i>, 28<\/b>, 474\u2013486 (2001)."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Altekruse SF, Mcglynn KA, Reichman ME. Hepatocellular carcinoma incidence, mortality, and survival trends in the united states from 1975 to 2005. J. Clin. Oncol.<\/i>, 27<\/b>, 1485\u20131491 (2009).","DOI":"10.1200\/JCO.2008.20.7753"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Li T, Zhong J, Dong X, Xiu P, Wang F, Wei H, Wang X, Xu Z, Liu F, Sun X, Li J. Meloxicam suppresses hepatocellular carcinoma cell proliferation and migration by targeting cox-2\/pge2-regulated activation of the \u03b2-catenin signaling pathway. Oncol. Rep.<\/i>, 35<\/b>, 3614\u20133622 (2016).","DOI":"10.3892\/or.2016.4764"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Xiao B, Lin D, Zhang X, Zhang M, Zhang X. Ttf1, in the form of nanoparticles, inhibits angiogenesis, cell migration and cell invasion in vitro<\/i> and in vivo<\/i> in human hepatoma through stat3 regulation. Molecules<\/i>, 21<\/b>, 1507 (2016).","DOI":"10.3390\/molecules21111507"},{"key":"9","unstructured":"9) Fan SJ, Li WL, Cui WX, Zhong WC, Yang YL, Zhu GF. Determination of total alkaloids in the extract of Toddalia asiatica by acid dye colorimetry. Acta Universitatis Traditionis Medicalis Sinensis Pharmacologiaeque Shanghai<\/i>, 1<\/b>, 85\u201389 (2012)."},{"key":"10","unstructured":"10) Lu Y, Zhu YZ, Cuo CX, Han C, Zhu GF, Pan YY. Study on analgesic effects of Toddalia asiatica extract and its mechanism. Shanghai Journal of Traditional Chinese Medicine<\/i>, 7<\/b>, 82\u201386 (2015)."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Zhang ZF, Guo Y, Zhang JB, Wei XH. Induction of apoptosis by chelerythrine chloride through mitochondrial pathway and bcl-2 family proteins in human hepatoma smmc-7721 cell. Arch. Pharm. Res.<\/i>, 34<\/b>, 791\u2013800 (2011).","DOI":"10.1007\/s12272-011-0513-5"},{"key":"12","unstructured":"12) Wang PQ, Yin ZH, Kang WY. Research progress of pharmacological activity of chelerythrine. Chung Kuo Chung Yao Tsa Chih<\/i>, 38<\/b>, 19\u201323 (2013)."},{"key":"13","unstructured":"13) Walterov\u00e1 D, Ulrichov\u00e1 J, V\u00e1lka I, Vicar J, Vavreckov\u00e1 C, T\u00e1borsk\u00e1 E, Harjrader RJ, Meyer DL, Cern\u00e1 H, Sim\u00e1nek V. Benzo[c]phenanthridine alkaloids sanguinarine and chelerythrine: biological activities and dental care applications. Acta Univ. Palacki. Olomuc. Fac. Med.<\/i>, 139<\/b>, 7\u201316 (1995)."},{"key":"14","unstructured":"14) Zda\u0159ilov\u00e1 A, Mal\u00edkov\u00e1 J, Dvo\u0159\u00e1k Z, Ulrichov\u00e1 J, \u0160im\u00e1nek V. Quaternary isoquinoline alkaloids sanguinarine and chelerythrine. In vitro<\/i> and in vivo<\/i> effects. Chemicke Listy<\/i>, 100<\/b>, 30\u201341 (2006)."},{"key":"15","unstructured":"15) Han C, Zhu GF. Mechanism of apoptosis induced by Chelerythrine in HepG2 cells. Chinese Journal of Experimental Traditional Medical Formulae<\/i>, 11<\/b>, 127\u2013130 (2016)."},{"key":"16","unstructured":"16) Steeg PS. Tumor metastasis: mechanistic insights and clinical challenges. Nat. Med.<\/i>, 12<\/b>, 895\u2013904 (2006)."},{"key":"17","unstructured":"17) Luzzi KJ, Macdonald IC, Schmidt EE, Kerkvliet N, Morris VL, Chambers AF, Groom AC. Multistep nature of metastatic inefficiency : dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am. J. Pathol.<\/i>, 153<\/b>, 865\u2013873 (1998)."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Liu J, Wen X, Liu B, Zhang Q, Zhang J, Miao H, Zhu R. Diosmetin inhibits the metastasis of hepatocellular carcinoma cells by downregulating the expression levels of mmp-2 and mmp-9. Molecular Medicine Reports<\/i>, 13<\/b>, 2401\u20132408 (2016).","DOI":"10.3892\/mmr.2016.4872"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Mason SD, Joyce JA. Proteolytic networks in cancer. Trends Cell Biol.<\/i>, 21<\/b>, 228\u2013237 (2011).","DOI":"10.1016\/j.tcb.2010.12.002"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Tian T, Nan KJ, Guo H, Wang WJ, Ruan ZP, Wang SH, Liang X, Lu CX. Pten inhibits the migration and invasion of hepg2 cells by coordinately decreasing mmp expression via<\/i> the pi3k\/akt pathway. Oncol. Rep.<\/i>, 23<\/b>, 1593\u20131600 (2010).","DOI":"10.3892\/or_00000800"},{"key":"21","unstructured":"21) Brouxhon SM, Kyrkanides S, Teng X, Athar M, Ghazizadeh S, Simon M, O\u2019Banion MK, Ma L. Soluble e-cadherin: a critical oncogene modulating receptor tyrosine kinases, mapk and pi3k\/akt\/mtor signaling. Oncogene<\/i>, 33<\/b>, 225\u2013235 (2014)."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Yang N, Hui L, Wang Y, Yang H, Jiang X. Sox2 promotes the migration and invasion of laryngeal cancer cells by induction of mmp-2 via<\/i> the pi3k\/akt\/mtor pathway. Oncol. Rep.<\/i>, 31<\/b>, 2651\u20132659 (2014).","DOI":"10.3892\/or.2014.3120"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Lin CW, Shen SC, Chien CC, Yang LY, Shia LT, Chen YC. 12-o-tetradecanoylphorbol-13-acetate-induced invasion\/migration of glioblastoma cells through activating pkcalpha\/erk\/nf-kappab-dependent mmp-9 expression. J. Cell. Physiol.<\/i>, 225<\/b>, 472\u2013481 (2010).","DOI":"10.1002\/jcp.22226"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Woo JH, Lim JH, Kim YH, Suh SI, Min DS, Chang JS, Lee YH, Park JW, Kwon TK. Resveratrol inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting jnk and pkc delta signal transduction. Oncogene<\/i>, 23<\/b>, 1845\u20131853 (2004).","DOI":"10.1038\/sj.onc.1207307"},{"key":"25","unstructured":"25) Qin W, Wang T. Research progress of cytoskeleton and cell migration. Chinese Journal of Ethnomedicine and Ethnopharmacy<\/i>, 23<\/b>, 24\u201325 (2014)."},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Bauvois B. New facets of matrix metalloproteinases mmp-2 and mmp-9 as cell surface transducers: outside-in signaling and relationship to tumor progression. Biochim. Biophys. Acta<\/i>, 1825<\/b>, 29\u201336 (2012).","DOI":"10.1016\/j.bbcan.2011.10.001"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Lustosa SA, Viana Lde S, Affonso RJ Jr, Silva SR, Denadai MV, de Toledo SR, Oliveira ID, Matos D. Expression profiling using a cdna array and immunohistochemistry for the extracellular matrix genes fn-1, itga-3, itgb-5, mmp-2, and mmp-9 in colorectal carcinoma progression and dissemination. ScientificWorldJournal<\/i>, 2014<\/b>, 102541 (2014).","DOI":"10.1155\/2014\/102541"},{"key":"28","unstructured":"28) Daniele A, Abbate I, Oakley C, Casamassima P, Savino E, Casamassima A, Sciortino G, Fazio V, Gadaleta-Caldarola G, Catino A, Giotta F, De Luca R, Divella R. Clinical and prognostic role of matrix metalloproteinase-2, -9 and their inhibitors in breast cancer and liver diseases: a review. Int. J. Biochem. Cell Biol.<\/i>, 77<\/b> (Pt A), 91\u2013101 (2016)."},{"key":"29","unstructured":"29) Xu Tl, Xie SL, Wang GY. The recent progress in the study of signal transduction pathway in hepatocellular carcinoma cells. Chinese Journal of Gerontology<\/i>, 33<\/b>, 1724\u20131726 (2013)."},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Reunanen N, Westermarck J, H\u00e4kkinen L, Holmstr\u00f6m TH, Elo I, Eriksson JE, Kahari VM. Enhancement of fibroblast collagenase (matrix metalloproteinase-1) gene expression by ceramide is mediated by extracellular signal-regulated and stress-activated protein kinase pathways. J. Biol. Chem.<\/i>, 273<\/b>, 5137\u20135145 (1998).","DOI":"10.1074\/jbc.273.9.5137"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Han J, Jeon M, Shin I, Kim S. Elevated stc-1 augments the invasiveness of triple-negative breast cancer cells through activation of the jnk\/c-jun signaling pathway. Oncol. Rep.<\/i>, 36<\/b>, 1764\u20131771 (2016).","DOI":"10.3892\/or.2016.4977"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Wu YJ, Neoh CA, Tsao CY, Su JH, Li HH. Sinulariolide suppresses human hepatocellular carcinoma cell migration and invasion by inhibiting matrix metalloproteinase-2\/-9 through mapks and pi3k\/akt signaling pathways. Int. J. Mol. Sci.<\/i>, 16<\/b>, 16469\u201316482 (2015).","DOI":"10.3390\/ijms160716469"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Lin JJ, Su JH, Tsai CC, Chen YJ, Liao MH, Wu YJ. 11-epi-sinulariolide acetate reduces cell migration and invasion of human hepatocellular carcinoma by reducing the activation of erk1\/2, p38mapk and fak\/pi3k\/akt\/mtor signaling pathways. Mar. Drugs<\/i>, 12<\/b>, 4783\u20134798 (2014).","DOI":"10.3390\/md12094783"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Zhang ZF, Guo Y, Zhang JB, Wei XH. Induction of apoptosis by chelerythrine chloride through mitochondrial pathway and bcl-2 family proteins in human hepatoma smmc-7721 cell. Arch. Pharm. Res.<\/i>, 34<\/b>, 791\u2013800 (2011).","DOI":"10.1007\/s12272-011-0513-5"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Vrba J, Dolezel P, Vicar J, Modriansk\u00fd M, Ulrichov\u00e1 J. Chelerythrine and dihydrochelerythrine induce g1 phase arrest and bimodal cell death in human leukemia hl-60 cells. Toxicol. In Vitro<\/i>, 22<\/b>, 1008\u20131017 (2008).","DOI":"10.1016\/j.tiv.2008.02.007"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Liu F, Zhang ZF, Wei XH. Study on the inhibitory effect of Chelerythrine on cervical cancer cell. Progress in Modern Biomedicine<\/i>, 9<\/b>, 514\u2013516 (2009).","DOI":"10.1016\/S0084-3954(08)79195-4"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Kwon M, Lee SJ, Wang Y, Rybak Y, Luna A, Reddy S, Adem A, Beaty BT, Condeelis JS, Libutti SK. Filamin a interacting protein 1-like inhibits wnt signaling and mmp expression to suppress cancer cell invasion and metastasis. Int. J. Cancer<\/i>, 135<\/b>, 48\u201360 (2014).","DOI":"10.1002\/ijc.28662"},{"key":"38","unstructured":"38) Fidler IJ. Tumor heterogeneity and the biology of cancer invasion and metastasis. Cancer Res.<\/i>, 38<\/b>, 2651\u20132660 (1978)."},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Elkington PTG, Friedland JS. Matrix metalloproteinases in destructive pulmonary pathology. Thorax<\/i>, 61<\/b>, 259\u2013266 (2006).","DOI":"10.1136\/thx.2005.051979"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) de Necochea-Campion R, Zuckerman LM, Mirshahidi HR, Khosrowpour S, Chen C-S, Mirshahidi S. Metastatic biomarkers in synovial sarcoma. Biomarker Research<\/i>, 5<\/b>, 4 (2017).","DOI":"10.1186\/s40364-017-0083-x"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Chen S, Liu W, Wang K, Fan Y, Chen J, Ma J, Wang X, He D, Zeng J, Li L. Tetrandrine inhibits migration and invasion of human renal cell carcinoma by regulating akt\/nf-\u03bab\/mmp-9 signaling. PLOS ONE<\/i>, 12<\/b>, e0173725 (2017).","DOI":"10.1371\/journal.pone.0173725"},{"key":"42","unstructured":"42) Buccione R, Caldieri G, Ayala I. Invadopodia: specialized tumor cell structures for the focal degradation of the extracellular matrix. Cancer Metastasis Rev.<\/i>, 28<\/b>, 137\u2013149 (2009)."},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Zhao J, Guan JL. Signal transduction by focal adhesion kinase in cancer. Cancer Metastasis Rev.<\/i>, 28<\/b>, 35\u201349 (2009).","DOI":"10.1007\/s10555-008-9165-4"},{"key":"44","unstructured":"44) Sulzmaier FJ, Jean C, Schlaepfer DD. Fak in cancer: mechanistic findings and clinical applications. Nat. Rev. Cancer<\/i>, 14<\/b>, 598\u2013610 (2014)."},{"key":"45","unstructured":"45) Golubovskaya VM. Targeting fak in human cancer: from finding to first clinical trials. Front. Biosci.<\/i>, 19<\/b>, 687\u2013706 (2014)."},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Canel M, Secades P, Garz\u00f3narango M, Allonca E, Suarez C, Serrels A, Frame M, Brunton V, Chiara MD. Involvement of focal adhesion kinase in cellular invasion of head and neck squamous cell carcinomas via<\/i> regulation of mmp-2 expression. Br. J. Cancer<\/i>, 98<\/b>, 1274\u20131284 (2008).","DOI":"10.1038\/sj.bjc.6604286"},{"key":"47","unstructured":"47) Shibata K, Kikkawa F, Nawa A, Thant AA, Naruse K, Mizutani S, Hamaguchi M. Both focal adhesion kinase and c-ras are required for the enhanced matrix metalloproteinase 9 secretion by fibronectin in ovarian cancer cells. Cancer Res.<\/i>, 58<\/b>, 900\u2013903 (1998)."},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Sein TT, Thant AA, Hiraiwa Y, Amin AR, Sohara Y, Liu Y, Matsuda S, Yamamoto T, Hamaguchi M. A role for fak in the concanavalin \u03b1-dependent secretion of matrix metalloproteinase-2 and -9. Oncogene<\/i>, 19<\/b>, 5539\u20135542 (2000).","DOI":"10.1038\/sj.onc.1203932"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Jeong YJ, Choi Y, Shin JM, Cho HJ, Kang JH, Park KK, Choe JY, Bae YS, Han SM, Kim CH, Chang HW, Chang YC. Melittin suppresses egf-induced cell motility and invasion by inhibiting pi3k\/akt\/mtor signaling pathway in breast cancer cells. Food & Chemical Toxicology An International Journal Published for the British Industrial Biological Research Association<\/i>, 68<\/b>, 218\u2013225 (2014).","DOI":"10.1016\/j.fct.2014.03.022"},{"key":"50","unstructured":"50) Kun G. Study on the molecular mechanism of heat shock protein 27 promoting invasion and metastasis of human hepatocellular carcinoma<\/i>, Doctoral dissertation, Fudan University (2007)."},{"key":"51","doi-asserted-by":"crossref","unstructured":"51) Lin JJ, Su JH, Tsai CC, Chen YJ, Liao MH, Wu YJ. 11-epi-sinulariolide acetate reduces cell migration and invasion of human hepatocellular carcinoma by reducing the activation of erk1\/2, p38mapk and fak\/pi3k\/akt\/mtor signaling pathways. Mar. Drugs<\/i>, 12<\/b>, 4783\u20134798 (2014).","DOI":"10.3390\/md12094783"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52) Lai KC, Huang AC, Hsu SC, Kuo CL, Yang JS, Wu SH, Chung JG. Benzyl isothiocyanate (bitc) inhibits migration and invasion of human colon cancer ht29 cells by inhibiting matrix metalloproteinase-2\/-9 and urokinase plasminogen (upa) through pkc and mapk signaling pathway. J. Agric. Food Chem.<\/i>, 58<\/b>, 2935\u20132942 (2010).","DOI":"10.1021\/jf9036694"}],"container-title":["Biological & Pharmaceutical Bulletin","Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/41\/1\/41_b17-00451\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,5]],"date-time":"2019-10-05T10:15:49Z","timestamp":1570270549000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/41\/1\/41_b17-00451\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b17-00451","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}